Jeffrey B. Mirviss - Dec 3, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Dec 3, 2022
Transactions value $
-$13,794
Form type
4
Date filed
12/5/2022, 03:20 PM
Previous filing
Apr 21, 2022
Next filing
Dec 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Gift $0 -26 -0.02% $0.00 110K May 16, 2022 Direct
transaction BSX Common Stock Gift $0 -230 -0.21% $0.00 111K Nov 1, 2022 Direct F1
transaction BSX Common Stock Options Exercise $0 +649 +0.59% $0.00 111K Dec 3, 2022 Direct F2
transaction BSX Common Stock Tax liability -$13.8K -296 -0.27% $46.60 111K Dec 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -649 -50% $0.00 649 Dec 3, 2022 Common Stock 649 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares acquired on June 30, 2022 under the Boston Scientific Employee Stock Purchase Plan (formerly Boston Scientific Global Employee Stock Purchase Plan) based upon the most current data available.
F2 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 3, 2019, the first anniversary of the date of grant.